文献速递外周动脉疾病

BEST-CLI 试验中慢性肢体威胁性缺血开放与血管内血运重建后的二次干预

Secondary interventions following open vs endovascular revascularization for chronic limb threatening ischemia in the BEST-CLI trial.
PubMed 文献 · J Vasc Surg · 2024-02-17

该研究为 BEST-CLI 随机试验的计划性二次分析,比较初始开放旁路(OPEN)与血管内(ENDO)策略的再干预终点。队列1(有合适单段大隐静脉,n=1434)中 OPEN 显著降低主要再干预(HR 0.37)、任何再干预(HR 0.63)及再干预、截肢或死亡复合终点(HR 0.68);队列2(缺乏合适单段大隐静脉,n=396)结果相似。

要点

  • 队列1中初始开放旁路较血管内治疗显著降低主要肢体再干预风险(HR 0.37)。
  • 两队列中随机分配至血管内治疗者30天肢体再干预率均高于开放旁路。
  • 再干预多数发生在随机化后第一年,但随访期间事件持续累积。

核心结论

  • 在适合两种方式的患者中,初始开放旁路尤其在有可用单段大隐静脉导管时,与显著较少的主要和次要目标肢体再干预相关。

研究设计与样本

  • BEST-CLI 随机试验的计划性二次分析,按意向性治疗比较初始开放旁路与血管内治疗策略,队列1有合适单段大隐静脉(n=1434),队列2缺乏合适单段大隐静脉(n=396)。

主要发现

  • 队列1中 OPEN 较 ENDO 显著降低主要肢体再干预风险(HR 0.37;95%CI 0.28-0.49;P<.001)。
  • 队列1中 OPEN 较 ENDO 显著降低任何再干预风险(HR 0.63;95%CI 0.53-0.75;P<.001)。
  • 队列1中 OPEN 较 ENDO 显著降低再干预、截肢或死亡复合终点风险(HR 0.68;95%CI 0.60-0.78;P<.001)。
  • 队列2中 OPEN 较 ENDO 显著降低主要再干预风险(HR 0.53;95%CI 0.33-0.84;P=.007)及任何再干预风险(HR 0.71;95%CI 0.52-0.98;P=.04)。
  • 30天肢体再干预率 ENDO 高于 OPEN:队列1为14.7% vs 4.5%,队列2为16.6% vs 5.6%。

关键数值与推荐

  • 队列1中 OPEN 较 ENDO 每年主要再干预平均事件数比显著更低(MR 0.45;95%CI 0.34-0.58;P<.001)。
  • 队列1中 OPEN 较 ENDO 每年任何目标肢体再干预平均事件数比显著更低(MR 0.67;95%CI 0.57-0.80;P<.001)。
  • 队列1中 OPEN 较 ENDO 每挽救肢体每年主要再干预平均事件数比更低(MR 0.45;95%CI 0.35-0.57;P<.001),任何再干预亦更低(MR 0.66;95%CI 0.55-0.79;P<.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Patients undergoing revascularization for chronic limb-threatening ischemia experience a high burden of target limb reinterventions. We analyzed data from the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) randomized trial comparing initial open bypass (OPEN) and endovascular (ENDO) treatment strategies, with a focus on reintervention-related study endpoints. METHODS: In a planned secondary analysis, we examined the rates of major reintervention, any reintervention, and the composite of any reintervention, amputation, or death by intention-to-treat assignment in both trial cohorts (cohort 1 with suitable single-segment great saphenous vein [SSGSV], n = 1434; cohort 2 lacking suitable SSGSV, n = 396). We also compared the cumulative number of major and all index limb reinterventions over time. Comparisons between treatment arms within each cohort were made using univariable and multivariable Cox regression models. RESULTS: In cohort 1, assignment to OPEN was associated with a significantly reduced hazard of a major limb reintervention (hazard ratio [HR], 0.37; 95% confidence interval [CI], 0.28-0.49; P < .001), any reintervention (HR, 0.63; 95% CI, 0.53-0.75; P < .001), or any reintervention, amputation, or death (HR, 0.68; 95% CI, 0.60-0.78; P < .001). Findings were similar in cohort 2 for major reintervention (HR, 0.53; 95% CI, 0.33-0.84; P = .007) or any reintervention (HR, 0.71; 95% CI, 0.52-0.98; P = .04). In both cohorts, early (30-day) limb reinterventions were notably higher for patients assigned to ENDO as compared with OPEN (14.7% vs 4.5% of cohort 1 subjects; 16.6% vs 5.6% of cohort 2 subjects). The mean number of major (mean events per subject ratio [MR], 0.45; 95% CI, 0.34-0.58; P < .001) or any target limb reinterventions (MR, 0.67; 95% CI, 0.57-0.80; P < .001) per year was significantly less in the OPEN arm of cohort 1. The mean number of reinterventions per limb salvaged per year was lower in the OPEN arm of cohort 1 (MR, 0.45; 95% CI, 0.35-0.57; P < .001 and MR, 0.66; 95% CI, 0.55-0.79; P < .001 for major and all, respectively). The majority of index limb reinterventions occurred during the first year following randomization, but events continued to accumulate over the duration of follow-up in the trial. CONCLUSIONS: Reintervention is common following revascularization for chronic limb-threatening ischemia. Among patients deemed suitable for either approach, initial treatment with open bypass, particularly in patients with available SSGSV conduit, is associated with a significantly lower number of major and minor target limb reinterventions.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Conte MS, Azene E, Doros G, et al. Secondary interventions following open vs endovascular revascularization for chronic limb threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2024. PMID: 38368997. doi:10.1016/j.jvs.2024.02.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。